Antimicrobial Retainer with Light Activation for MRSA Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for preventing and treating nosocomial infections in healthcare settings are limited in providing immediate protection and are ineffective against antibiotic-resistant strains of bacteria such as MRSA and Staphylococcus epidermidis, as well as viruses like HSV-1, which pose significant health and economic burdens.

Innovation Solution

A system and method utilizing a retainer that combines an antimicrobial solution with specific wavelengths of light to create a synergistic effect, enhancing the antimicrobial activity and providing therapeutic treatment by retaining the solution against tissue while exposing it to certain wavelengths of light, thereby eliminating or reducing microorganisms causing disease.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antibiotic modalities are used to treat nosocomial infections, then treatment effectiveness is improved, but antibiotic resistance increases

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidantibiotic resistance
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent combines light therapy with antimicrobial solutions to create a synergistic treatment approach. The light source activates the antimicrobial solution to produce reactive oxygen species that kill bacteria, while the retainer ensures prolonged contact between the activated solution and the infection site. This combination provides effective treatment without relying solely on antibiotics, thereby addressing antibiotic resistance.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent changes the physical state and chemical properties of the antimicrobial solution through light activation. The light source transforms the antimicrobial solution from an inactive state to an active state with high oxidative potential, enabling it to effectively kill resistant bacteria. The retainer maintains optimal concentration and contact time parameters for sustained therapeutic effect.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If current infection control protocols are implemented, then prevention measures are established, but immediate protection against resistant strains is insufficient

Engineering Contradiction:
Improveinfection preventionVSAvoidimmediate protection capability
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent applies the treatment preoperatively to eliminate bacteria before surgery, preventing infection before it occurs. The retainer is applied to the surgical site beforehand, and the antimicrobial solution is activated by light to create a protective barrier against potential contamination during surgery. This preliminary action provides immediate protection that current protocols cannot achieve.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The retainer serves as an intermediary device that bridges the gap between the antimicrobial solution and the infection site. It ensures prolonged and consistent contact between the activated solution and the tissue, enhancing the effectiveness of the treatment while allowing for immediate protection against resistant strains.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If antimicrobial solutions are applied to tissue, then antimicrobial activity is achieved, but the effect duration is limited without prolonged contact

Engineering Contradiction:
Improveantimicrobial activityVSAvoidsolution contact time
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The retainer is designed to maintain continuous contact between the antimicrobial solution and the treatment site for an extended period. The flexible retainer conforms to the body part and holds the solution in place, ensuring uninterrupted therapeutic action. This continuous contact allows the activated antimicrobial solution to effectively eliminate bacteria over time, addressing both acute and persistent infections.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The combination of antimicrobial solutions and light wavelengths achieves a greater antimicrobial effect than either component alone, effectively reducing or eliminating nosocomial infection-causing pathogens, including MRSA and HSV-1, with potential for preoperative and postoperative use.

Implementation Method 1

a number of fiber optic cables having a first end connected to a light source and a second end connected to a number of light terminations rigidly connected to the retainer

Methodology Applied
Scientific EffectOptical fiber transmission: Optical Fibre

Implementation Method 2

a number of heating elements connected to the retainer for therapeutic treatment

Methodology Applied
Scientific EffectJoule heating: Joule Heating

Implementation Method 3

The combination of antimicrobial solutions and light wavelengths achieves a greater antimicrobial effect than either component alone

Methodology Applied
Scientific EffectPhotochemical reaction: Photo-oxidation

Data Source

PatentUS10293148B2System, retainer and method of preventing and treating nosocomial infections including methicillin-resistant <i>Staphylococcus aureus </i>infections
Publication Date: 2019.05.21 DABNEY PAUL
  • US10293148B2 patent drawing
  • US10293148B2 patent drawing
  • US10293148B2 patent drawing

AI summary

According to an exemplary embodiment, a retainer for therapeutic treatment may be provided. The retainer for therapeutic treatment may include: a retainer that may retain a antimicrobial solution against tissue; a number of heating elements connected to the retainer for therapeutic treatment; a number of power supply cables connected to the number of heating elements; a number of antimicrobial solution delivery elements connected to the retainer for therapeutic treatment that may deliver an antimicrobial solution; a number of pieces of tubing having a first end connected to a antimicrobial solution reservoir and a second end connected to a number of antimicrobial solution delivery elements; a number of fiber optic cables having a first end connected to a light source; and a number of light terminations rigidly connected to the retainer for therapeutic treatment and connected to the second end of the fiber optic cable.